Healthcare - Biotechnology - NASDAQ - US
$ 0.6
-14.3 %
$ 877 M
Market Cap
None
P/E
BALANCE SHEET
510 M
ASSETS
285 M
LIABILITIES
225 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
immatics biotechnologies GmbH
| Current Assets | 449 M |
| Cash & Short-Term Investments | 426 M |
| Receivables | 5.74 M |
| Other Current Assets | 17.7 M |
| Non-Current Assets | 60.6 M |
| Long-Term Investments | 0 |
| PP&E | 57.1 M |
| Other Non-Current Assets | 3.54 M |
| Current Liabilities | 157 M |
| Accounts Payable | 7.67 M |
| Short-Term Debt | 2.6 M |
| Other Current Liabilities | 146 M |
| Non-Current Liabilities | 128 M |
| Long-Term Debt | 12.8 M |
| Other Non-Current Liabilities | 116 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 218.5 | 148.5 | 133.0 | 207.5 | 103.4 | 39.4 |
| Short Term Investments | 207.4 | 213.7 | 12.1 | 24.4 | 16.0 | 13.1 |
| Receivables | 5.7 | 2.1 | 0.7 | 2.9 | 2.7 | 1.8 |
| Inventory | 0 | 1 | 1 | 3.3 | 1.2 | 1 |
| Other Current Assets | 17.7 | 12.8 | 4.7 | 4.1 | 1.9 | 1.0 |
| Total Current Assets | 449.4 | 377.2 | 152.2 | 239.0 | 124.0 | 55.3 |
| PP&E | 57.1 | 26.5 | 20.5 | 14.0 | 8.0 | 4.0 |
| Intangible Assets | 1.5 | 1.6 | 1.3 | 0.9 | 1.0 | 1.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 2.0 | 2.5 | 0.6 | 0.7 | 1.3 | 1.0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 510.0 | 407.8 | 174.6 | 254.6 | 134.3 | 61.3 |
| LIABILITIES | ||||||
| Accounts Payable | 7.7 | 4.0 | 3.0 | 2.6 | 4.9 | 4.2 |
| Short Term Debt | 2.6 | 2.2 | 2.7 | (15.0) | 1.4 | 0 |
| Other Current Liabilities | 38.0 | 27.6 | 37.3 | 8.4 | 2.7 | 0.9 |
| Total Current Liabilities | 156.6 | 106.5 | 95.1 | 60.6 | 69.3 | 26.8 |
| Long Term Debt | 12.8 | 12.4 | 7.1 | 4.3 | 1.8 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | (4.3) | 0 | 0 |
| Other Liabilities | 115.5 | 75.8 | 48.3 | 0 | 104.0 | 0.2 |
| Total Liabilities | 284.9 | 194.7 | 150.6 | 150.4 | 175.1 | 70.5 |
| EQUITY | ||||||
| Common Stock | 0.8 | 0.8 | 0.6 | 0.6 | 1.2 | 1.2 |
| Retained Earnings | (597.3) | (500.3) | (537.8) | (462.3) | (233.2) | (201.6) |
| Other Accumulative Comprehensive Income/Loss | (1.6) | (1.5) | (3.9) | (7.5) | (0.8) | (0.7) |
| Total Equity | 225.1 | 213.2 | 24.1 | 104.3 | (40.8) | (9.2) |
| Total Liabilities and Equity | 510.0 | 407.8 | 174.6 | 254.6 | 134.3 | 61.3 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 80.5 | 67.2 | 62.9 | 48.0 | 62.9 | 62.9 |